Follicular lymphoma is a type of non-Hodgkin lymphoma, a cancer that begins in the lymphatic system. It primarily affects B-cells, which are a type of white blood cell involved in fighting infections. The exact cause of follicular lymphoma is not well understood, but it is associated with genetic mutations and immune system dysfunction. It often progresses slowly, and common symptoms include painless swelling of lymph nodes, fatigue, unexplained weight loss, fever, and night sweats. Diagnosis typically involves a combination of physical exams, imaging tests like CT or PET scans, and a biopsy of the affected lymph node to confirm the presence of cancerous cells.
The treatment approach for follicular lymphoma depends on the stage of the disease, symptoms, and overall health of the patient. For early-stage follicular lymphoma, radiation therapy may be sufficient. However, in more advanced stages or when symptoms are significant, a combination of therapies might be used. These can include chemotherapy, targeted therapy (using drugs that specifically attack cancer cells), and immunotherapy (which boosts the body’s immune system to fight the cancer). In some cases, watchful waiting, where the patient is closely monitored without immediate treatment, may be recommended if the lymphoma is not causing symptoms. Treatment aims to manage the disease, reduce symptoms, and improve quality of life. Regular follow-ups are essential to monitor the disease’s progression and response to treatment.
Mr. Fred Kamanzi from Rwanda successfully received treatment for Follicular Lymphoma at Yashoda Hospitals, Hyderabad, under the supervision of Dr. Nikhil S Ghadyalpatil, Director – Medical Oncology, Senior Consultant Medical Oncologist & Hemato-Oncologist.